# Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy

> **NCT01760616** · PHASE4 · TERMINATED · sponsor: **Qidong Gaitianli Medicines Co., Ltd** · enrollment: 790 (actual)

## Conditions studied

- Hepatic Carcinoma

## Interventions

- **DRUG:** Huaier Granule

## Key facts

- **NCT ID:** NCT01760616
- **Lead sponsor:** Qidong Gaitianli Medicines Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11-07
- **Primary completion:** 2015-08-15
- **Final completion:** 2017-06-30
- **Target enrollment:** 790 (ACTUAL)
- **Why stopped:** difficult to recruit patients
- **Last updated:** 2020-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760616, "Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01760616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*